NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-phenyl-2,3-dihydro-1H-indene-1,3-dione
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Athrombon
|
Bindan
|
Cronodione
|
Danedion
|
Danilon
|
Danilone
|
Diadilan
|
Dindevan
|
Dineval
|
Diophindane
|
Emandion
|
Emandione
|
Eridione
|
Fenhydren
|
Fenilin
|
Fenindion
|
Hedulin
|
Hemolidione
|
Indema
|
Indion
|
Indon
|
PID
|
Phenhydren
|
Phenillin
|
Phenylen
|
Phenylin
|
Phenylindanedione
|
Phenylindione
|
Phenyline
|
Phenyllin
|
Pindione
|
Rectadione
|
Theradione
|
Thrombasal
|
Tromazal
|
Trombol
|
|
|
Synonyms
|
Phenindione
|
Dindevan
|
Rectadione
|
Phenindione
|
2-Phenyl-1,3-indandione
|
2-phenyl-1H-indene-1,3(2H)-dione
|
2-phenylindane-1,3-dione
|
2-PHENYL-1,3-INDANEDIONE
|
2-phenyl-2,3-dihydro-1H-indene-1,3-dione
|
苯茚二酮
|
2-苯基-1,3-茚满二酮
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
ATC CODE
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
4.875343
|
H Acceptors
|
2
|
H Donor
|
0
|
LogD (pH = 5.5)
|
2.1649199
|
LogD (pH = 7.4)
|
0.43830353
|
Log P
|
2.8809052
|
Molar Refractivity
|
65.2335 cm3
|
Polarizability
|
24.823254 Å3
|
Polar Surface Area
|
34.14 Å2
|
Rotatable Bonds
|
1
|
Lipinski's Rule of Five
|
true
|
Log P
|
3.1
|
LOG S
|
-3.98
|
Solubility (Water)
|
2.30e-02 g/l
|
DETAILS
DETAILS
MP Biomedicals
DrugBank
Selleck Chemicals
Wikipedia
Sigma Aldrich
DrugBank -
DB00498
|
Item |
Information |
Drug Groups
|
approved |
Description
|
An indandione that has been used as an anticoagulant. Phenindione has actions similar to warfarin, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234) |
Indication |
For the treatment of pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, mural thrombosis, and thrombophili. Also used for anticoagulant prophylaxis. |
Pharmacology |
Phenindione thins the blood by antagonizing vitamin K which is required for the production of clotting factors in the liver. Anticoagulants such as Phenindione have no direct effect on an established thrombus, nor do they reverse ischemic tissue damage (damage caused by an inadequate blood supply to an organ or part of the body). However, once a thrombus has occurred, the goal of anticoagulant treatment is to prevent further extension of the formed clot and prevent secondary thromboembolic complications which may result in serious and possibly fatal sequelae. Phenindione has actions similar to warfarin, but it is now rarely employed because of its higer incidence of severe adverse effects. |
Toxicity |
Oral, mouse: LD50 = 175 mg/kg; Oral, rat: LD50 = 163 mg/kg. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic. |
Absorption |
Absorbed slowly from the gastrointestinal tract. |
Half Life |
5-10 hours |
Protein Binding |
88% |
References |
|
External Links |
|
|
Selleck Chemicals -
S1921
|
Research Area: Immunology, Cardiovascular Disease Biological Activity: Phenindione(Rectadione) is an anticoagulant which functions as a Vitamin K antagonist. A lymphocyte transformation test showed proliferation of T-cells from the hypersensitive patient, but not from four controls on exposure to phenindione in vitro. Drug-specific T-cell clones were generated and characterized in terms of their phenotype, functionality, and mechanism of antigen presentation. Forty-three human leukocyte antigen class II restricted CD4+ αβ T-cell clones were identified. T-cell activation resulted in the secretion of interferon-γ and interleukin-5. [1][2] |
PATENTS
PATENTS
PubChem Patent
Google Patent